Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Real Brokerage (REAX) Research & Development (2020 - 2026)

Real Brokerage filings provide 7 years of Research & Development readings, the most recent being $5.1 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 30.9% to $5.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $18.7 million, a 36.92% increase, with the full-year FY2025 number at $17.4 million, up 43.49% from a year prior.
  • Research & Development hit $5.1 million in Q1 2026 for Real Brokerage, up from $4.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $5.1 million in Q1 2026 to a low of $1.0 million in Q4 2022.
  • Median Research & Development over the past 5 years was $2.5 million (2024), compared with a mean of $2.8 million.
  • The widest YoY moves for Research & Development: up 10908.11% in 2022, down 47.92% in 2022.
  • Real Brokerage's Research & Development stood at $1.0 million in 2022, then skyrocketed by 132.04% to $2.3 million in 2023, then surged by 73.85% to $4.0 million in 2024, then increased by 18.9% to $4.8 million in 2025, then increased by 7.1% to $5.1 million in 2026.
  • The last three reported values for Research & Development were $5.1 million (Q1 2026), $4.8 million (Q4 2025), and $4.7 million (Q3 2025) per Business Quant data.